Summit Creek Advisors LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Summit Creek Advisors LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2022$8,336,000
+19.6%
131,860
+0.4%
0.94%
+34.9%
Q4 2021$6,967,000
-22.8%
131,357
+2.8%
0.70%
-26.6%
Q3 2021$9,020,000
+15.6%
127,783
+9.2%
0.95%
+2.4%
Q2 2021$7,800,000
-42.1%
117,047
-3.6%
0.93%
-42.0%
Q1 2021$13,472,000
-7.7%
121,362
-1.3%
1.61%
-14.3%
Q4 2020$14,600,000
+28.2%
122,950
-5.8%
1.87%
+10.8%
Q3 2020$11,387,000
-0.4%
130,510
+2.3%
1.69%
+0.4%
Q2 2020$11,428,000127,6001.68%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders